A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant

Cell Res. 2022 May;32(5):495-497. doi: 10.1038/s41422-022-00631-z. Epub 2022 Feb 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing
  • COVID-19 Vaccines
  • COVID-19*
  • Primates
  • SARS-CoV-2*

Substances

  • Antibodies, Neutralizing
  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants